年内涨超60%！葛兰在管中欧医疗创新暂停大额申购，单日单账户最多10万

澎湃新闻2025-08-09

中欧基金投资总监葛兰旗下在管医药基金主题加入“限流”行列。　　8月9日，中欧基金公告称，为进一步保证基金稳定运作，保护基金份额持有人利益，决定自8月11日起，对葛兰旗下在管的中欧医疗创新股票型证券投资基金（下称“中欧医疗创新”）暂停大额申购、转换转入及定期定额投资，单日单账户限购10万元。　　2019年10月23日，中欧医疗创新曾在直销渠道限制申购、转换转入、定期定额投资业务，限购金额为单日单...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558501040?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-09 19:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2558501040","market":"hk","top_or_hot":-1,"title":"年内涨超60%！葛兰在管中欧医疗创新暂停大额申购，单日单账户最多10万","media":"澎湃新闻","content":"<div>\n<p>中欧基金投资总监葛兰旗下在管医药基金主题加入“限流”行列。 　　8月9日，中欧基金公告称，为进一步保证基金稳定运作，保护基金份额持有人利益，决定自8月11日起，对葛兰旗下在管的中欧医疗创新股票型证券投资基金（下称“中欧医疗创新”）暂停大额申购、转换转入及定期定额投资，单日单账户限购10万元。　　2019年10月23日，中欧医疗创新曾在直销渠道限制申购、转换转入、定期定额投资业务，限购金额为单日单...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202508093480577136.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>年内涨超60%！葛兰在管中欧医疗创新暂停大额申购，单日单账户最多10万</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n年内涨超60%！葛兰在管中欧医疗创新暂停大额申购，单日单账户最多10万\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-09 19:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202508093480577136.html><strong>澎湃新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中欧基金投资总监葛兰旗下在管医药基金主题加入“限流”行列。 　　8月9日，中欧基金公告称，为进一步保证基金稳定运作，保护基金份额持有人利益，决定自8月11日起，对葛兰旗下在管的中欧医疗创新股票型证券投资基金（下称“中欧医疗创新”）暂停大额申购、转换转入及定期定额投资，单日单账户限购10万元。　　2019年10月23日，中欧医疗创新曾在直销渠道限制申购、转换转入、定期定额投资业务，限购金额为单日单...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202508093480577136.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0417516571.SGD","symbol_name":"Allianz Oriental Income Cl AT Acc SGD","start_time":0,"source_url":"http://finance.eastmoney.com/a/202508093480577136.html","article_id":"2558501040","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202508093480577136.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558501040","pubTimestamp":1754737523,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"中欧基金投资总监葛兰旗下在管医药基金主题加入“限流”行列。8月9日，中欧基金公告称，为进一步保证基金稳定运作，保护基金份额持有人利益，决定自8月11日起，对葛兰旗下在管的中欧医疗创新股票型证券投资基金（下称“中欧医疗创新”）暂停大额申购、转换转入及定期定额投资，单日单账户限购10万元。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0417516571.SGD":"Allianz Oriental Income Cl AT Acc SGD","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0140636845.USD":"施罗德大中华区股票A Acc","02268":"药明合联","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0823426480.USD":"法巴中国股票经典Dis","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0823426308.USD":"法巴中国股票基金","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","LU0359201612.USD":"贝莱德中国基金A2","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0196878994.USD":"MANULIFE GF CHINA VALUE \"AA\" (USD) INC","BK1576":"医药外包概念","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","LU0051755006.USD":"摩根大通中国A (dist)","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU1688375341.USD":"贝莱德中国灵活股票基金","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","BK1161":"生物科技","BK1610":"ETF&股票定投概念","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","BK1593":"医美概念股","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","02269":"药明生物","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU0348783233.USD":"安联东方收入型 CI A Dis美元","01530":"三生制药","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0348784397.USD":"ALLIANZ ORIENTAL INCOME \"A\" (USD) ACC","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","BK1583":"高瓴概念","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","09926":"康方生物","06990":"科伦博泰生物-B","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","BK1521":"挪威政府全球养老基金持仓"},"translate_title":"It rose by more than 60% during the year! Gulen is in charge of China-Europe Medical Innovation and suspends large-amount subscriptions, with a single account of up to 100,000 per day","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1,"09926":1,"02269":1,"02268":1,"06990":1},"content_text":"中欧基金投资总监葛兰旗下在管医药基金主题加入“限流”行列。 　　8月9日，中欧基金公告称，为进一步保证基金稳定运作，保护基金份额持有人利益，决定自8月11日起，对葛兰旗下在管的中欧医疗创新股票型证券投资基金（下称“中欧医疗创新”）暂停大额申购、转换转入及定期定额投资，单日单账户限购10万元。　　2019年10月23日，中欧医疗创新曾在直销渠道限制申购、转换转入、定期定额投资业务，限购金额为单日单账户500万元。2020年3月9日起该限制取消。　　如果不算直销渠道此前的限制举措，这次可以视作中欧医疗创新自2019年成立以来首次进行全渠道的大额限购。 　　公开资料显示，中欧医疗创新成立于2019年2月，是葛兰目前唯一单独在管的医药主题基金；此前7月4日，葛兰旗下在管规模最大的医药主题基金——中欧医疗健康混合发布公告称，增聘赵磊为基金经理。早在2021年1月，中欧医疗健康也曾宣布在代销渠道限购10万元，并延续至今。　　据Wind数据，截至今年二季度末，中欧医疗创新规模为81.14亿元；从基金业绩情况来看，截至2025年8月8日，中欧医疗创新A年内收益率达62.28%，在同类983只基金中排名第29。而中欧医疗健康A在二季度末的规模为308.01亿元，年初至今的收益率为21.81%，同类排名1078/4525。　　从中欧医疗创新6月末的前十大重仓股持仓情况来看，三生制药（01530.HK）、新诺威（300765.SZ）首次新进该基金的持仓前十。其中，葛兰于2024年下半年首次买入三生制药，彼时该股还位列持仓第34位，持仓数量为105.60万股；截至2025年二季度末，三生制药已跃升为中欧医疗创新的头号重仓股，持仓数量为3382.50万股。　　另一方面，中欧医疗创新减持了科伦博泰生物（06990.HK）、康方生物（09926.HK）、药明合联（02268.HK）、药明生物（02269.HK）、百利天恒（688506.SH）、药明康德（603259.SH）、凯莱英（002821.SZ）与恒瑞医药（600276.SH）。　　除了中欧医疗创新，中欧基金今日还公告，自8月11日起，由基金经理邵洁管理的中欧科创主题混合也宣布单日账户限购100万元。　　整体来看，近日已有多只绩优基金加入“限流”行列。据澎湃新闻记者统计，全市场年内收益率超50%的基金已达153只（仅计算初始基金，下同），其中有22只产品已暂停申购或启动限购，占比为14.38%。　　另单独从主动权益基金情况来看（普通股票型基金、偏股混合型基金、灵活配置型基金、平衡偏股型基金），年内收益率超40%的主动权益基金高达216只，其中有28只产品已暂停申购或启动限购，占比为12.96%。　　具体来看，除葛兰外，广发基金吴远怡、华夏基金顾鑫峰、汇添富基金张韡、景顺长城基金农冰立、永赢基金高楠等多位知名基金经理旗下在管基金纷纷“控流”。　　“基金限购通过控制资金流入节奏，既能保障投资策略的稳定性，又能减少投资者的冲动性追涨，优化持有体验。”有业内人士指出，限购并非看空市场，而是对策略有效性的主动维护。“规模激增后的核心矛盾在于，策略容量与流动性难以匹配。以红利主题基金为例，若遭遇短期资金涌入，可能迫使基金经理被动调仓，增加交易成本并错失股息再投资机会。”（文章来源：澎湃新闻）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558501040","isCrawlerRequest":true}